Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Candidemia D058387 2 associated lipids
Blastomycosis D001759 5 associated lipids
Aspergillosis D001228 5 associated lipids
Vaginitis D014627 6 associated lipids
Xerostomia D014987 6 associated lipids
Gonorrhea D006069 7 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Otitis Externa D010032 8 associated lipids
Urethritis D014526 9 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Perez R et al. The effect of topically applied antimycotic agents on inner ear vestibular and cochlear function. 2013 Laryngoscope pmid:22991276
Godoy JS et al. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis. 2013 J. Oral Pathol. Med. pmid:22978344
Pinelli LA et al. Ricinus communis treatment of denture stomatitis in institutionalised elderly. 2013 J Oral Rehabil pmid:23438045
Kim DH et al. Differential regulation of CC chemokine ligand 2 and CXCL8 by antifungal agent nystatin in macrophages. 2013 Biochem. Biophys. Res. Commun. pmid:23831464
Manzoni P et al. Prevention of nosocomial infections in neonatal intensive care units. 2013 Am J Perinatol pmid:23292914
Ouyang W et al. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells. 2013 Int. J. Oncol. pmid:23258590
Siljamäki E et al. Cholesterol dependence of collagen and echovirus 1 trafficking along the novel α2β1 integrin internalization pathway. 2013 PLoS ONE pmid:23393580
Daneman N et al. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. 2013 Lancet Infect Dis pmid:23352693
Shi L et al. Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. 2013 Nat Commun pmid:23385580
Hu R et al. Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary invasive fungal infections that originate in the throat of patients with hematologic malignancies. 2013 Neoplasma pmid:23374002
Perchyonok VT et al. Chitosan and gelatin based prototype delivery systems for the treatment of oral mucositis: from material to performance in vitro. 2013 Curr Drug Deliv pmid:23017090
Al-Jubory AR and Handy RD Uptake of titanium from TiOâ‚‚ nanoparticle exposure in the isolated perfused intestine of rainbow trout: nystatin, vanadate and novel COâ‚‚-sensitive components. 2013 Nanotoxicology pmid:23020080
Austin N et al. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. 2013 Cochrane Database Syst Rev pmid:23543519
Martín-Villena MJ et al. Novel microparticulate systems for the vaginal delivery of nystatin: development and characterization. 2013 Carbohydr Polym pmid:23544502
Pál S et al. Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system. 2013 Eur J Pharm Sci pmid:23528741
Wang W et al. The interaction of polysaccharide from Auricularia polytricha with quantum dots and the protection of plasmid DNA from damage. 2013 Appl. Biochem. Biotechnol. pmid:23440638
Monteiro DR et al. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. 2013 Mycoses pmid:23773119
El-Wahidi M et al. [Bio-guided isolation of an antifungal from Haliclona enamela collected from Jorf Lasfar port, Morocco]. 2013 J Mycol Med pmid:23726234
Tevyashova AN et al. Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. 2013 Antimicrob. Agents Chemother. pmid:23716057
Gerstein AC Mutational effects depend on ploidy level: all else is not equal. 2013 Biol. Lett. pmid:23054913
Marín-Quintero D et al. Formulation design and optimization for the improvement of nystatin-loaded lipid intravenous emulsion. 2013 J Pharm Sci pmid:23970386
Torres-Alvarez B et al. Cutaneous congenital candidiasis in a full-term newborn from an asymptomatic mother. 2013 Dermatol. Online J. pmid:24010513
Lin TY et al. Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. 2013 Cell Rep pmid:24268777
Chen Z et al. [The clinical research of nystatin in prevention of invasive fungal infections in patients on mechanical ventilation in intensive care unit]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24021043
Reis DC et al. Structural studies and investigation on the activity of imidazole-derived thiosemicarbazones and hydrazones against crop-related fungi. 2013 Molecules pmid:24129274
Tugizov SM et al. Epstein-Barr virus transcytosis through polarized oral epithelial cells. 2013 J. Virol. pmid:23698302
Maroszyńska M et al. Antibiotics sensitivity of Candida clinical and food-borne isolates. 2013 Acta Biochim. Pol. pmid:24432323
Stoopler ET Management of oral chronic graft-versus-host disease. 2013 J Can Dent Assoc pmid:23763728
Ceccarelli G et al. Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation. 2013 Crit Care pmid:23414732
Thiessen N et al. [Squamous cell carcinoma developing in oral lichen planus]. 2013 Hautarzt pmid:24127014
Hothersall JD et al. Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization. 2013 Br. J. Pharmacol. pmid:23581504
Bosanquet DC et al. Topical steroids for chronic wounds displaying abnormal inflammation. 2013 Ann R Coll Surg Engl pmid:23676816
Semis R et al. Mechanism of activity and toxicity of Nystatin-Intralipid. 2013 Med. Mycol. pmid:23088298
Heneedak HM et al. HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin. 2012 Nov-Dec J Chromatogr Sci pmid:22879356
Alcântara CS et al. Peel bond strength of resilient liner modified by the addition of antimicrobial agents to denture base acrylic resin. 2012 Nov-Dec J Appl Oral Sci pmid:23329241
Houlton JJ et al. Intranasal drug-induced fungal rhinopharyngitis. 2012 Mar-Apr Int Forum Allergy Rhinol pmid:22253034
Kaufman DA "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. 2012 Early Hum. Dev. pmid:22633513
Khan MA et al. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. 2012 FEMS Immunol. Med. Microbiol. pmid:22612788
Gerstein AC et al. Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast. 2012 Genetics pmid:22714405
Kaomongkolgit R et al. Antifungal activity of coronarin D against Candida albicans. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22727093
Mima EG et al. Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. 2012 Clin. Microbiol. Infect. pmid:22731617
Fernández Campos F et al. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. 2012 J Pharm Sci pmid:22777575
Kalema N et al. Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. 2012 PLoS ONE pmid:22808020
Bzik VA et al. Mechanisms of action of zinc on rat intestinal epithelial electrogenic ion secretion: insights into its antidiarrhoeal actions. 2012 J. Pharm. Pharmacol. pmid:22471360
Semis R et al. Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice. 2012 J. Antimicrob. Chemother. pmid:22499997
Leibovitz E Strategies for the prevention of neonatal candidiasis. 2012 Pediatr Neonatol pmid:22503254
Caliceti C et al. Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. 2012 PLoS ONE pmid:22859971
Kovac M et al. Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin. 2012 J Clin Pharm Ther pmid:21332566
Hingston CD et al. Impact of nystatin on Candida and the oral microbiome. 2012 Crit Care pmid:22827886
Giglio M et al. Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial. 2012 Crit Care pmid:22490643